A Meta-Analysis of PCSK9 Inhibitors Versus Statins for LDL Cholesterol Reduction and Cardiovascular Outcomes. ccm. 2025;9(6):491-498. Accessed September 17, 2026. https://fortunejournals.org/ojs/index.php/ccm/article/view/16664